Respiratory News: Breaking Respiratory News, Comments and Articles. - Page: 2

11:37 EST 1st March 2015 | BioPortfolio

Respiratory News - Page: 2Twitter RSS

Read the latest Respiratory News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Respiratory.

Search or Follow Our Respiratory - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Respiratory - Page: 2 News.
You can also follow our Respiratory - Page: 2 news stories on Twitter: @Respiratory_Bio

Showing "respiratory airways lungs breath" News Articles 26 to 50 of 2,700+

Thursday 26th February 2015

Meridian Bioscience Receives CE Marking for Two New Molecular Amplification Tests: illumigene® Chlamydia and illumigene® Gonorrhea

Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has received the CE Mark for two new molecular diagnostic tests for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), the sixth and seventh assays on the illumigene® platform. Along with these two new assays, Meridian also received the CE Mark for an innovat...

Parkinson’s Disease (PD): EU Commission Approves Xadago® (Safinamide) for Mid-Late Stage PD Patients

The European Commission approves the use of Xadago® as add-on to L-dopa alone or in combination with other PD medications in mid-late stage PD patients with motor fluctuations Zambon S.p.A., an international pharmaceutical company strongly committed to the Central Nervous System (CNS) therapeutic area, and its partner Newron Pharmaceuticals S.p.A. (...

Audentes Therapeutics Joins Global Organizations in Celebrating Rare Disease Day® 2015

New Audentes Patient Advocacy Website Created to Serve Patient Community Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, today announced its support for Rare Disease Day®, to be held on February 28th, 2015. The theme of thi...

Teva to Present at the Cowen & Company 35th Annual Healthcare Conference

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the Cowen & Company 35th Annual Healthcare Conference in Boston, MA. Siggi Olafsson, President & CEO, Global Generic Medicine Group will present on Tuesday, March 3, 2015 at 8:40 AM EST   ...

Afferent Clinical Data for Lead Candidate, AF-219, Demonstrate Improvements in Pain and Urinary Urgency in Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

- Findings Presented at the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) 2015 Winter Meeting - Afferent Pharmaceuticals, a leader in the development of small molecule compounds targeting P2X3 for the treatment of respiratory and urologic disorders, as well as chronic pain, today announced presentation of results f...

WHO is Notified of Four Cases of MERS-CoV in Saudi Arabia

Between Feb. 20, 2015 and Feb. 22, 2015, the National IHR Focal Point for the Kingdom of Saudi Arabia notified the World Health Organization (WHO) of four additional cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, including one death. Details of the cases are as follows: A 58-year-old, non-national male from

Respiratory virus, HCV genotyping tests drive Q4 revenue growth for GenMark

Carlsbad, Calif.-based firm GenMark generated $9.8 million in revenue in the quarter ending Dec.  -More- 

Risk Factors of Pandemic Influenza A/H1N1

This household study identifies risk factors of infection by the pandemic influenza A/H1N1. Influenza and Other Respiratory Viruses

New CDC study highlights burden of pneumonia hospitalizations on U.S. children

ATLANTA, Feb. 26, 2015 /PRNewswire-USNewswire/ -- Children younger than 5 years of age accounted for 70 percent of pneumonia hospitalizations among children, the Centers for Disease Control and Prevention reported in a study published today. Pneumonia remains a leading cause of hospitalization among children in the United States. The two-and-a-half-year study published in the New England Jour...

AbbVie Launches SigueElGuion.com to Educate Spanish-Speaking Americans about Hypothyroidism and the Importance of Dialogue between Patient and Healthcare Professional

NORTH CHICAGO, Ill., Feb. 26, 2015 /PRNewswire/ -- To further awareness about the importance of diagnosing and treating hypothyroidism, a thyroid condition that affects millions of Americans, AbbVie (NYSE: ABBV) launched the Spanish-language website SigueElGuion.com. The website features information on symptoms of hypothyroidism and discusses one potential treatment option, ...

Dr. Shawn Khodadadian of Manhattan Gastroenterology Named Top Doctor: New York Metro Area

NEW YORK, Feb. 26, 2015 /PRNewswire/ -- Dr. Shawn Khodadadian of Manhattan Gastroenterology (http://www.manhattangastroenterology.com) in NYC has been named by Castle Connolly as a "Top Doctor" in the New York Metro area. Dr. Khodadadian, a Board Certified New York, NY gastroenterologist, has been selected by Castle Connolly Medical Ltd. for inclusion in its authoritative guide to the top spe...

Wednesday 25th February 2015

Korean Regulators Clear Masimo PVI(R) for Clinical Use

NEUCHATEL, SWITZERLAND -- (Marketwired) -- 02/26/15 -- Masimo (NASDAQ: MASI) announced today that the Republic of Korea's Ministry of Food and Drug Safety (MFDS) and the Korean Health Technology Assessment (HTA) group have cleared Masimo's noninvasive PVI® -- a measure of the dynamic changes in the perfusion index that occur during one or more complete respiratory cycles -- for clinical use. Ko...

The AAPS Journal: Pharmacodynamic Studies to Demonstrate Bioequivalence of Oral Inhalation Products

Type: ReportIn the session on “Pharmacodynamic studies to demonstrate efficacy and safety”, presentations were made on methods of evaluating airway deposition of inhaled corticosteroids and bronchodilators, and systemic exposure indirectly using ...

Viruses Increasingly Behind Child Pneumonia Cases

WEDNESDAY, Feb. 25, 2015 -- Young children are at increased risk of becoming seriously ill with pneumonia -- but unlike in years past, the cause is usually a respiratory virus, a large U.S. study finds. The researchers found that 66 percent of...

Respiratory viruses most common cause of pneumonia in children, study finds

Respiratory viruses, not bacterial infections, are the most commonly detected causes of community-acquired pneumonia in children, according to new research released Feb. 26 in the New England Journal of Medicine.

Cystic fibrosis discovery may lead to new treatment strategy, help patients breathe easier

A team led by UC San Francisco professor of medicine John Fahy, MD, has discovered why mucus in the lungs of people with cystic fibrosis (CF) is thick, sticky and difficult to cough up, leaving these patients more vulnerable to lung infection.

Sunovion Pharmaceuticals Inc. Announces Initiation of Phase 3 Clinical Trial Program for SUN-101/eFlow® (Glycopyrrolate) in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)

SUN-101/eFlow® is the first nebulized long-acting muscarinic antagonist (LAMA) drug/device combination product in Phase 3 development The SUN-101/eFlow® Phase 3 program consists of three clinical trials which will enroll approximately 2,340 adults with moderate-to-very severe COPD SUN-101/eFlow® is a...

Local Boy Raises Awareness for #PHAware and Rare Disease Day® February 28

LOS ANGELES, Feb. 25, 2015 /PRNewswire/ -- If you haven't heard of pulmonary hypertension, one boy, his father and a local credit union want to change that.  First Entertainment Credit Union, the entertainment industry, and celebrities Laura Dern, Courteney Cox, Florence Henderson and Jeffrey Hayzlett are rallying for the cause. Even NASDAQ gave a shoutout with a Tweet last week to its 3...

AstraZeneca enters autoimmune diseases pact with Orca

AstraZeneca has signed a three-year research deal with the UK-based biotech firm Orca to develop treatments for autoimmune diseases. The companies will collaborate to produce retinoic acid-related orphan nuclear receptor gamma (RORγ) inhibitors. RORγ – proteins found in the lungs, liver and kidneys – play a key role in the immune system. read more

Neos Therapeutics Completes $20.6 Million Financing to Further Advance its Late-Stage ADHD Product Pipeline

Neos Therapeutics, Inc. (“Neos” or “the Company”), a specialty pharmaceutical company with a late-stage pipeline of innovative extended-release (“XR”) products for Attention-Deficit Hyperactivity Disorder (“ADHD”), today announced that it has completed an oversubscribed round of financing, raising a total of $20.6 million. The financing inc...

AZ taps Orca for oral T cell inhibitors

AstraZeneca (AZ) has forged an R&D alliance with Orca Pharmaceuticals focusing on the development of a new class of compound with potential in autoimmune disease therapy.UK-based Orca was formed in 2013 to concentrate on the development of inhibi...

Henry Ford Wyandotte Hospital: A 100 Best Hospital

WYANDOTTE, Mich., Feb. 25, 2015 /PRNewswire/ -- Henry Ford Wyandotte Hospital has been recognized as one of America's 100 Best Hospitals™ by Healthgrades® in 2015. Only 100 of the nation's more than 4,400 hospitals received this distinction for clinical quality. America's 100 Best Hospitals, according to Healthgrades, a consumer website, are among the top 2 percent of hospit...

Using challenge models for early differentiation in respiratory diseases: Finding early signals for potential mechanism of action.

At the 2014 Exploratory Clinical  Development World Europe, Carol Astbury, Head, Early Development & Global Project Leader Respiratory TA, Almirall S.A, gave a presentation on “Using ... The post Using challenge models for early differentiation in respiratory diseases: Finding early signals for potential mechanism of action. appeared first on Total Biopharma.

EarlySense Further Increases its Presence in Asian Markets with Regulatory Clearance and a New Leading Distributor in South Korea

RAMAT GAN, Israel, February 25, 2015 /PRNewswire/ -- EarlySense®, the market leader in contact-free monitoring solutions, today announced receiving an approval to distribute the EarlySense System including the Bedside Monitor and Central Display System in the Korean Market. The Korean selling license and KGMP approval for EarlySense is another major regulatory milestone in a rapidly growing ...

Flexible nanosensors for wearable devices

Scientists will now be able to fabricate optical nanosensors capable of sticking to uneven surfaces and biological surfaces, like human skin. This result can boost the use of wearable devices to monitor parameters such as temperature, breath and hear...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks